Health
Nigeria On Alert After Ebola Outbreak Confirmed In Uganda – NCDC DG
Joel Ajayi
Director-General of the Nigeria Centre for Disease Control and Prevention (NCDC), Dr. Jide Idris, has announced that the country is on high alert following the confirmation of an Ebola Virus Disease (EVD) outbreak in Uganda.
He disclosed this on Sunday during an interview in Abuja.Idris stated that while Nigeria has no reported cases of Ebola, the NCDC, in collaboration with key stakeholders, has heightened surveillance measures to prevent the virus from being imported into the country.He explained that the outbreak, caused by the Sudan strain of the virus, was confirmed by Uganda’s Ministry of Health on January 30, 2025.“So far, one case and one death have been reported in Wakiso, Mukono, and Mbale City in Mbale District.
“Ugandan health authorities are currently tracking 44 contacts to curb further spread,” he added.In response to the outbreak, Idris said that the NCDC has taken several measures, including updating its Ebola Virus Disease (EVD) emergency contingency plan, increasing screening at points of entry—particularly international airports—and optimizing diagnostic capacity for EVD testing in designated laboratories.He added that the agency has also mobilized Lassa fever testing laboratories, which can be scaled up for Ebola testing if needed.
The NCDC Director-General assured Nigerians that proactive steps were being taken to mitigate any risk of an outbreak.
“While there is no immediate cause for panic, we must remain vigilant. The Ebola Sudan strain has no approved vaccine, making early detection and containment critical,” he said.
He urged Nigerians to follow key preventive measures, including practicing good hand hygiene by washing hands regularly with soap and water or using hand sanitizers.He advised avoiding contact with individuals showing symptoms such as fever, weakness, vomiting, and unexplained bleeding, as well as refraining from consuming bushmeat, particularly bats and primates.
“Seek immediate medical attention if you experience symptoms after traveling to an affected country,” he emphasized.
Additionally, Idris called on health workers to maintain a high index of suspicion, use personal protective equipment (PPE), and report suspected cases immediately.Idris noted that while the World Health Organization (WHO) has not recommended travel restrictions, he advised Nigerians to avoid non-essential travel to countries with confirmed Ebola cases
“Travelers returning from affected countries in the last 21 days with symptoms such as fever, sore throat, vomiting, or unexplained bleeding should immediately call the NCDC toll-free number (6232) or their State Ministry of Health hotline,” he emphasized.
Beyond Ebola, he highlighted that Nigeria is currently battling outbreaks of Lassa fever, meningitis, diphtheria, Mpox, measles, and anthrax.Idris reaffirmed the NCDC’s commitment to strengthening surveillance and response efforts across the country.Ebola Virus Disease (EVD) is caused by the Ebola virus, which belongs to the Filoviridae family.There are five known strains of the virus, with the Zaire strain being the most deadly, followed by the Sudan strain.
Ebola is transmitted through direct contact with bodily fluids of infected individuals (blood, vomit, sweat, feces, saliva), contaminated objects, or infected animals.
The virus can spread through handling bushmeat, such as bats and primates, which are often carriers.Symptoms typically begin 2-21 days after exposure and include fever, fatigue, muscle pain, headache, sore throat, vomiting, diarrhea, rash, and unexplained bleeding or bruising.
As the disease progresses, organ failure and death may occur.Ebola outbreaks have occurred sporadically in several African countries, with the largest outbreak happening in West Africa between 2014 and 2016. The virus remains a public health concern in countries with known endemic transmission.
Health
Experts call for pharma sector harmonisation
Health sector experts have called for the harmonisation of pharmaceutical activities in Nigeria to eliminate duplication, enhance efficiency, and improve access to quality medicines and health products.
The call was made on Wednesday in Abuja during a high-level stakeholders’ engagement focused on aligning efforts under the Improving Access to Medicines through Policy and Technical Support (IMPACT) project.
Dr Tayo Hamzat, Supply Chain Management Officer at the World Health Organisation (WHO), said the engagement was timely, considering the number of ongoing but uncoordinated interventions in the sector.
“Harmonisation will lead to faster access to health products, lower costs, improved efficiency, and better regulatory oversight.
“It requires collaboration and a focus on strengthening national systems.”
He described Nigeria’s pharmaceutical system as “robust and huge” but hindered by weak coordination and fragmented management structures.
Dr Francis Ohanyido, Director-General of the West Africa Institute of Public Health, said such collaboration was “common sense” given limited development financing and the need to optimise resources.
“Market shaping is a critical tool.
“Harmonisation can help us identify clear gaps we need to fill, especially in preparation for the African Continental Free Trade Area (AfCFTA),” he said.
Dr Anthony Ayeke, Programme Manager for Health and Nutrition at the EU Delegation to Nigeria and ECOWAS, reaffirmed the EU’s commitment to supporting a resilient, locally driven pharmaceutical sector.
“Harmonisation can accelerate local production, reduce import dependency, and improve healthcare system resilience,” he noted.
He also recommended regulatory streamlining, value chain capacity building, innovation, and public-private partnerships.
Dr Abdu Mukhtar, National Coordinator of the Pharmaceutical Value Chain Transformation Committee (PVAC), commended ongoing efforts under the IMPACT project.
Represented by Dr Muhammad Balarabe, Technical Associate at PVAC, he emphasised the committee’s focus on catalysing local production and attracting sustainable investment.
“Let’s use this platform to strengthen partnerships and align interventions with the vision of affordable, high-quality healthcare for all Nigerians,” he said.
Dr Obi Adigwe, Director-General of the National Institute for Pharmaceutical Research and Development (NIPRD), said fragmented interventions and redundant regulations had long stunted growth in the sector.
Represented by Prof. Philip Builders, Professor of Pharmaceutics at NIPRD he said: “Equitable access to quality medicine is the foundation of universal healthcare.
“The lack of access is not just a health issue; it’s about equity, national security, and economic survival.
“Harmonisation isn’t just about avoiding duplication; it’s about aligning policy, investment, and technical frameworks to achieve measurable results.”
He urged stakeholders to develop practical short, medium, and long-term strategies to make Nigeria’s pharmaceutical sector self-reliant, globally competitive, and able to meet national healthcare demands.
The meeting brought together key government agencies, development partners, and private sector actors, each reaffirming a shared commitment to a unified, efficient pharmaceutical ecosystem in Nigeria.
NAN
-
Featured6 years agoLampard Names New Chelsea Manager
-
Featured5 years agoFG To Extends Lockdown In FCT, Lagos Ogun states For 7days
-
Featured6 years agoChildren Custody: Court Adjourns Mike Ezuruonye, Wife’s Case To April 7
-
Featured6 years agoNYSC Dismisses Report Of DG’s Plan To Islamize Benue Orientation Camp
-
Featured4 years agoTransfer Saga: How Mikel Obi Refused to compensate me After I Linked Him Worth $4m Deal In Kuwait SC – Okafor
-
Sports3 years ago
TINUBU LAMBAST DELE MOMODU
-
News9 months agoZulu to Super Eagles B team, President Tinubu is happy with you
-
Featured6 years ago
Board urges FG to establish one-stop rehabilitation centres in 6 geopolitical zones
